SCHEMBL18100388

SCHEMBL18100388

CCO/C(=N\c1ccccc1OC)c1cccc(C(=O)Nc2ccccc2C)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 3/20 0.50
▸ KMT2A Q03164 3/20 0.50
▸ ALDH1A1 P00352 3/20 0.50
▸ POLB P06746 3/20 0.46
▸ HPGD P15428 2/20 0.46
▸ GAA P10253 2/20 0.46
▸ TAS1R3 Q7RTX0 1/20 0.46
▸ TAS1R1 Q7RTX1 1/20 0.46
▸ TAS1R2 Q8TE23 1/20 0.46
▸ SMN1; SMN2 Q16637 2/20 0.44
▸ TDP1 Q9NUW8 1/20 0.44
▸ SIRT2 Q8IXJ6 1/20 0.44
▸ NPC1 O15118 2/20 0.44
▸ RAB9A P51151 1/20 0.44
▸ MAPT P10636 3/20 0.43
▸ PDE4D Q08499 1/20 0.43
▸ MAPK1 P28482 1/20 0.43
▸ AHR P35869 1/20 0.43
▸ LMNA P02545 1/20 0.43
▸ SMO Q99835 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18103144 0.94 SIRT2 (0.51) MEN1KMT2APOLBSMN1; SMN2TDP1
SCHEMBL18100298 0.84 NOS3 (0.44) MEN1KMT2AALDH1A1POLBGAA
SCHEMBL18103162 0.84 NOS3 (0.48) MEN1KMT2AALDH1A1POLBGAA
SCHEMBL10027983 0.76 NPC1 (0.55) MEN1KMT2AALDH1A1POLBHPGD
SCHEMBL18103120 0.72 MEN1 (0.53) MEN1KMT2AALDH1A1SMN1; SMN2SIRT2
SCHEMBL12077495 0.72 MEN1 (0.83) MEN1KMT2AALDH1A1POLBHPGD
SCHEMBL29808279 0.72 MEN1 (0.83) MEN1KMT2AALDH1A1POLBHPGD
SCHEMBL18100305 0.72 NOS3 (0.48) MEN1KMT2AALDH1A1POLBHPGD
SCHEMBL18103164 0.71 NOS3 (0.53) MEN1KMT2AALDH1A1POLBHPGD
SCHEMBL21311190 0.70 KMT2A (0.60) MEN1KMT2AALDH1A1POLBHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160280851-A1 IMINOETHER COMPOUND, POLYESTER RESIN COMPOSITION, METHOD FOR PRODUCING CARBOXYLIC ACID ESTER, POLYESTER FILM, BACK SHEET FOR SOLAR CELL MODULE, AND SOLAR CELL MODULE FUJIFILM CORPORATION (JP) 2016-09-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160280851-A1 IMINOETHER COMPOUND, POLYESTER RESIN COMPOSITION, METHOD FOR PRODUCING CARBOXYLIC ACID ESTER, POLYESTER FILM, BACK SHEET FOR SOLAR CELL MODULE, AND SOLAR CELL MODULE BRS3, RAD1, RAD51 MEN1 273/4885KMT2A 2801/4885ALDH1A1 1334/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback